NCT02956512View on ClinicalTrials.gov

Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

July 12, 2019

Study Completion Date

September 6, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Dexibuprofen

Dexibuprofen 300mg

Trial Locations (1)

03186010

Azidus laboratories Ltd., Valinhos

Sponsors
All Listed Sponsors
lead

Apsen Farmaceutica S.A.

INDUSTRY